You are here: Home » Current Affairs » Coronavirus » News
Over 50,000 Ayushman Bharat Health Centres now operational across India
Diabetic eye disease associated with five-fold risk of severe coronavirus
Business Standard

Coronavirus vaccine: How much it costs, who'll get it first and other FAQs

From Moderna, Pfizer to Oxford and Bharat Biotech coronavirus vaccine candidates, here's all you need to know about Covid-19 shots, who gets them first and what their cost may be

Topics
Coronavirus Vaccine | Coronavirus | Coronavirus Tests

BS Web Team  |  New Delhi 



Coronavirus, vaccine, covid, drugs, clinical trials

As the race for a vaccine nears its final lap with multiple phase 3 trials underway, the primary question has shifted from whether we will have a working vaccine at all to how much one (or more of them) will cost and who will get it first. As Dr Tedros Adhanom Ghebreyesus, the director general of the World Health Organization has said, it’s not over until it’s over everywhere --- it is essential that countries across the globe have access to the vaccine to put an end to the pandemic, which has claimed over 1,365,000 lives and counting.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.


We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, November 20 2020. 13:48 IST